Join the 200th Anniversary Celebration

Original Article

Improvement of Sleep Apnea in Patients with Chronic Renal Failure Who Undergo Nocturnal Hemodialysis

Patrick J. Hanly, M.D., and Andreas Pierratos, M.D.

N Engl J Med 2001; 344:102-107January 11, 2001

Abstract

Background

Sleep apnea is common in patients with chronic renal failure and is not improved by either conventional hemodialysis or peritoneal dialysis. With nocturnal hemodialysis, patients undergo hemodialysis seven nights per week at home, while sleeping. We hypothesized that nocturnal hemodialysis would correct sleep apnea in patients with chronic renal failure because of its greater effectiveness.

Methods

Fourteen patients who were undergoing conventional hemodialysis for four hours on each of three days per week underwent overnight polysomnography. The patients were then switched to nocturnal hemodialysis for eight hours during each of six or seven nights a week. They underwent polysomnography again 6 to 15 months later on one night when they were undergoing nocturnal hemodialysis and on another night when they were not.

Results

The mean (±SD) serum creatinine concentration was significantly lower during the period when the patients were undergoing nocturnal hemodialysis than during the period when they were undergoing conventional hemodialysis (3.9±1.1 vs. 12.8±3.2 mg per deciliter [342±101 vs. 1131±287 μmol per liter], P<0.001). The conversion from conventional hemodialysis to nocturnal hemodialysis was associated with a reduction in the frequency of apnea and hypopnea from 25±25 to 8±8 episodes per hour of sleep (P=0.03). This reduction occurred predominantly in seven patients with sleep apnea, in whom the frequency of episodes fell from 46±19 to 9±9 per hour (P= 0.006), accompanied by increases in the minimal oxygen saturation (from 89.2±1.8 to 94.1±1.6 percent, P=0.005), transcutaneous partial pressure of carbon dioxide (from 38.5±4.3 to 48.3±4.9 mm Hg, P=0.006), and serum bicarbonate concentration (from 23.2±1.8 to 27.8±0.8 mmol per liter, P<0.001). During the period when these seven patients were undergoing nocturnal hemodialysis, the apnea–hypopnea index measured on nights when they were not undergoing nocturnal hemodialysis was greater than that on nights when they were undergoing nocturnal hemodialysis, but it still remained lower than it had been during the period when they were undergoing conventional hemodialysis (P=0.05).

Conclusions

Nocturnal hemodialysis corrects sleep apnea associated with chronic renal failure.

Media in This Article

Figure 1The Study Protocol.
Figure 2Apnea–Hypopnea Index in Seven Patients with a Base-Line Apnea–Hypopnea Index Higher Than 15.
Article

Sleep disorders are common in patients with chronic renal failure.1-5 The reported prevalence of sleep apnea in such patients ranges from 50 percent to 70 percent.2 Although conventional hemodialysis does not reduce the prevalence or severity of sleep apnea in patients with chronic renal failure, renal transplantation has been reported to correct both obstructive and central sleep apnea.6-8

Nocturnal hemodialysis is a new technique that enables patients to undergo hemodialysis seven nights per week at home while sleeping.9 Since nocturnal hemodialysis provides better clearance of uremic toxins than conventional hemodialysis, it may improve sleep disorders, such as sleep apnea, that are associated with chronic renal failure. We performed a study to determine the effect of nocturnal hemodialysis on sleep apnea.

Methods

Study Subjects

Between November 1993 and November 1998, we studied 14 of the first 15 patients recruited to our nocturnal-hemodialysis program; the remaining patient declined to participate in the study after being switched to nocturnal hemodialysis. These patients were not assessed for the presence of sleep apnea before enrollment. Eligible patients had central venous access available for hemodialysis; had no contraindications to systemic anticoagulation; were able to learn the technique of nocturnal hemodialysis, in the opinion of the investigators; had a home environment appropriate for the support of nocturnal hemodialysis; and were English-speaking and thus able to respond to a telephone call prompted by remote monitoring. The study protocol was reviewed and approved by the research ethics board at St. Michael's Hospital, and all the patients gave written informed consent to participate in the study.

Nocturnal Hemodialysis

The nocturnal-hemodialysis program was a pilot study designed to assess this form of hemodialysis, which the patient undergoes at home, during sleep, for 8 to 10 hours every night. Vascular access was achieved through a long-term internal jugular catheter (Uldall catheter, Cook Critical Care, Bloomington, Ind.). A low flow of dialysate (100 ml per minute) was used to avoid excessive dialysis. A low-surface-area (0.7 m2) polysulfone dialyzer was used (Fresenius Medical Care, Lexington, Mass.). All the main functions displayed on the front panel of the dialysis machine (Fresenius 2008H) were monitored remotely each night by modem. Nocturnal hemodialysis provided clearance of small molecules at a rate at least twice that provided by conventional hemodialysis, excellent control of serum phosphate concentrations without the use of phosphate binders, improved clearance of medium-sized molecules, hemodynamic stability, control of blood pressure without the use of antihypertensive drugs, and an improved quality of life.10-14

Study Protocol

All patients entered the study while they were being treated with conventional hemodialysis for four hours on each of three days per week (Figure 1Figure 1The Study Protocol.). Base-line measurements consisting of polysomnography and biochemical studies were performed in the sleep laboratory on two different nights during one week. On one occasion, the measurements were performed after the patient had undergone conventional hemodialysis during the day, and on the other occasion, they were performed after a two-day interval during which the patient had not undergone conventional hemodialysis. The two nights when the studies were performed were scheduled in random order. Over the subsequent six weeks, the treatment was changed to nocturnal hemodialysis. After their condition had become stabilized while they were undergoing this treatment, the patients returned to the sleep laboratory for follow-up measurements performed on two different nights during one week; a night when the patient was being treated with nocturnal hemodialysis and a night when the patient was not undergoing nocturnal hemodialysis. Once again, the nights were scheduled in random order.

Study Measurements

The measurements consisted of comprehensive overnight polysomnography performed in a sleep laboratory and biochemical studies, which included measurements of serum creatinine and bicarbonate. The biochemical studies were performed just before and after polysomnography, and the values were averaged.

During overnight polysomnography, we obtained a two-channel electroencephalogram, an electro-oculogram, and a submental electromyogram using surface electrodes. The airflow was measured by monitoring expired carbon dioxide at the nose and mouth through nasal cannulas adapted for this purpose and attached to a carbon dioxide analyzer (CD 102, Normocap, Datex, Helsinki, Finland). Respiratory effort was measured by inductance plethysmography with transducers placed on the chest and abdomen (Respitrace, Ambulatory Monitoring, Ardsley, N.Y.). Arterial oxygen saturation was recorded with a pulse oximeter (Biox 3740, Ohmeda, Boulder, Colo.). The transcutaneous partial pressure of carbon dioxide was recorded by a sensor placed on the anterior chest wall and attached to a carbon dioxide monitor (Micro Gas 7640, Kontron Instruments, Watford, United Kingdom). Leg movements were measured by anterior tibialis electromyography from both legs with the use of surface electrodes. All variables were recorded continuously by a computerized data-acquisition system and stored on an optical disk for later analysis (Sandman, Mallinckrodt/Nellcor-Puritan Bennet, Melville, Ottawa, Ont., Canada).

All polysomnograms were scored manually according to established criteria.15 An arousal was defined as an awakening from sleep for 3 to 15 seconds, as reflected by simultaneous alpha activity on the electroencephalogram, electromyographic evidence of activation, and eye movements. A respiratory arousal was defined as an arousal that occurred within three seconds after the termination of an episode of apnea or hypopnea. Apnea was defined as the absence of airflow for more than 10 seconds. Hypopnea was defined as a reduction for more than 10 seconds in the amplitude of respiratory effort to a value between 10 and 50 percent of the base-line level during sleep, with or without an associated decrease in oxygen saturation. Episodes of apnea and hypopnea were classified as central if the chest wall and abdomen moved synchronously, as obstructive if they moved paradoxically, and as mixed if a central event was terminated by two or three obstructed breaths. The apnea–hypopnea index was defined as the number of episodes of apnea and hypopnea per hour of sleep. Cheyne–Stokes respiration was defined as an episode of central apnea (or hypopnea) alternating with breathing that had a pattern of crescendo and decrescendo.

The mean oxygen saturation and transcutaneous partial pressure of carbon dioxide during sleep were calculated by averaging the high and low values for each 30-second period. The mean minimal oxygen saturation was calculated by averaging the lowest oxygen value for each 30-second period. Periodic leg movements were defined as four or more involuntary leg movements during sleep, each lasting 0.5 to 5.0 seconds, with 5 to 90 seconds between movements.16

Statistical Analysis

Comparisons of two groups of mean values were made with Student's t-tests. Comparisons of three or four groups of mean values were made by analysis of variance for repeated measures with a Bonferroni test. All reported P values are two-sided.

Results

The patients were 10 men and 4 women with a mean (±SD) age of 45±9 years. They had been treated by conventional hemodialysis for 1 to 15 years. The cause of renal failure was chronic glomerulonephritis (in three patients), diabetes mellitus (in two), polycystic kidney disease (in two), hypertensive nephrosclerosis (in one), and reflux nephropathy (in one); the cause was unknown in five patients.

While the patients were undergoing conventional hemodialysis, the prevalence of sleep apnea, defined as an apnea–hypopnea index higher than 15, was 57 percent (Table 1Table 1Prevalence of Sleep Apnea during Treatment with Conventional Hemodialysis in 14 Patients with End-Stage Renal Disease.). One patient had Cheyne–Stokes respiration associated with an estimated left ventricular ejection fraction of 50 percent. Episodes of central, obstructive, and mixed apnea and hypopnea were equally distributed among the other patients. However, sleep apnea was diagnosed before enrollment in only one patient, who was treated with nasal continuous positive airway pressure throughout the study.

During the period when the patients were undergoing conventional hemodialysis, the mean serum creatinine concentration was elevated both two days after hemodialysis (12.8±3.2 mg per deciliter [1131±287 μmol per liter]) and on the day of dialysis (7.4±2.5 mg per deciliter [652±223 μmol per liter]). Although the serum creatinine concentrations were lower during nocturnal hemodialysis (3.9±1.1 mg per deciliter [342±101 μmol per liter], P<0.001), the concentration tended to increase on the single night when the patients were not undergoing nocturnal hemodialysis (5.7±1.7 mg per deciliter [506±148 μmol per liter], P<0.001). The mean serum bicarbonate concentration was lowest (22.9±2.6 mmol per liter) two days after conventional hemodialysis, indicating greater metabolic acidosis in patients who had not undergone dialysis for more than 48 hours.

There were no substantial changes in sleep patterns during the study (Table 2Table 2Mean (±SD) Polysomnographic Data According to the Type of Hemodialysis.). The frequency of arousals and periodic leg movements was higher than normal16 but remained stable. The apnea–hypopnea index decreased substantially after the treatment was converted from conventional to nocturnal hemodialysis, and it tended to increase during the single night when the patient was not undergoing nocturnal hemodialysis. The mean transcutaneous partial pressure of carbon dioxide during sleep was lowest two days after conventional hemodialysis, a result consistent with the ventilatory response to metabolic acidosis noted above.

The polysomnographic data in the seven patients who had sleep apnea (apnea–hypopnea index greater than 15), excluding the single patient who continued to receive nasal continuous positive airway pressure throughout the study, are shown in Table 3Table 3Mean (±SD) Polysomnographic Data in Seven Patients with an Apnea–Hypopnea Index above 15.. There was a reduction in the apnea–hypopnea index after conversion from conventional to nocturnal hemodialysis, accompanied by an increase in oxygen saturation during sleep. The mean transcutaneous partial pressure of carbon dioxide was significantly higher during the period when the patients were undergoing nocturnal hemodialysis, whereas their serum bicarbonate concentration was lowest two days after a session of conventional hemodialysis. Although the frequency of all arousals (respiratory plus nonrespiratory) remained high, the frequency of respiratory arousals fell significantly, from 25±14 per hour when measured two days after conventional hemodialysis to 6±7 per hour during nocturnal hemodialysis (P= 0.008). In the single patient with Cheyne–Stokes respiration, the apnea–hypopnea index remained elevated (Figure 2Figure 2Apnea–Hypopnea Index in Seven Patients with a Base-Line Apnea–Hypopnea Index Higher Than 15.), but the pattern of breathing became more characteristic of obstructive sleep apnea.

There was an even and consistent distribution of central, obstructive, and mixed episodes of apnea and hypopnea during the period when the patients were being treated by conventional hemodialysis (Table 4Table 4Type of Episode of Apnea or Hypopnea.). Furthermore, the reduction in the apnea–hypopnea index after treatment was changed to nocturnal hemodialysis was similar for all categories of apnea and hypopnea.

The body-mass index (the weight in kilograms divided by the square of the height in meters) did not change significantly in patients with sleep apnea (25.9 ±5.6 during conventional hemodialysis and 25.9±5.0 during nocturnal hemodialysis) or in those without sleep apnea (25.5±4.1 and 25.6±3.6, respectively).

Discussion

Our findings confirm the high prevalence of sleep apnea in patients with end-stage renal disease1-4 and demonstrate that nocturnal hemodialysis improves sleep apnea. Although sleep apnea is clearly associated with chronic renal failure, the natural history of the association has not been determined. In the majority of our patients, sleep apnea was not apparent until chronic renal failure had become established, the problem persisted during conventional hemodialysis, and snoring and witnessed apnea resolved shortly after conversion to nocturnal hemodialysis. These results contrast with the findings in the single patient who had obstructive sleep apnea before chronic renal failure developed. This patient was treated with nasal continuous positive airway pressure throughout the study and continued to have severe obstructive sleep apnea when this treatment was discontinued (apnea–hypopnea index, 65), despite successful conversion from conventional to nocturnal hemodialysis.

Despite reductions in the apnea–hypopnea index and associated respiratory arousals after the conversion to nocturnal hemodialysis, the number of total arousals remained high. This observation reflects the multiple causes of sleep disruption in patients with chronic renal failure, which includes sleep apnea, periodic limb movements, and conditioned insomnia associated with many years of sleep disruption. The majority of persistent arousals during nocturnal hemodialysis either were associated with periodic limb movements or were classified as “spontaneous,” in that they were not temporally related to periodic limb movements or environmental noise. Dialysate flow was minimized in this study (100 ml per minute) in order to prevent excessive dialysis. It is possible that higher dialysate and blood flows would further relieve sleep fragmentation.

The pathogenesis of sleep apnea in patients with end-stage renal disease is not clear, although many hypotheses have been considered.1,2,17,18 It is characterized by features of both obstructive and central apnea.3,5,6 In our patients with sleep apnea, there was an even distribution of central, obstructive, and mixed respiratory events. These findings support the hypothesis that sleep apnea in patients with chronic renal failure is due both to central destabilization of ventilatory control and to upper-airway occlusion. The respiratory adaption to chronic metabolic acidosis in chronic renal failure promotes the development of hypocapnia,5,6,19 which has a key role in the pathogenesis of periodic breathing.20 This destabilization is augmented by increased chemosensitivity, which has been reported in patients with end-stage renal disease19 and in the pathogenesis of periodic breathing.20

During conventional hemodialysis, our patients had relative hypocapnia, reflected by mean values for the transcutaneous partial pressure of carbon dioxide that were at the lower end of the normal range; these values increased significantly after the initiation of nocturnal hemodialysis. The development of periodic breathing can promote upper-airway occlusion both by reducing drive to the upper airway muscles during apnea and by disproportionately increasing drive to the inspiratory muscles.21,22 This combination is more likely to cause obstructive apnea in patients with chronic renal failure than in healthy persons, since those with chronic renal failure may be predisposed to upper-airway occlusion because they have airway edema, which is associated with fluid overload, and reduced muscle tone, which is associated with uremia and neuropathy.1,6

We did not evaluate every potential mechanism by which nocturnal hemodialysis might improve sleep apnea, although we believe the increase in the transcutaneous partial pressure of carbon dioxide reflects stabilization of ventilatory control. We speculate that the change from Cheyne–Stokes respiration to obstructive sleep apnea in one of our patients resulted from increased respiratory drive in association with an unstable upper airway. However, it is possible that the correction of sleep apnea in our patients was mediated primarily through the effect of nocturnal hemodialysis on the upper airway. Nocturnal hemodialysis improves the control of blood pressure by decreasing the volume of extracellular fluid.13 Such a decrease, particularly in the upper airway, may have a salutary effect on the pathophysiology of sleep apnea.

Supported by a grant from the Ontario Ministry of Health.

We are indebted to Kristine Thornley, Bert Lee, Michaelene Ouwendyk, and Robert Francoeur for their technical assistance. This article is dedicated to the memory of Dr. Robert Uldall.

Source Information

From the Department of Medicine, St. Michael's Hospital (P.J.H.), and Humber River Regional Hospital (A.P.), University of Toronto, Toronto.

Address reprint requests to Dr. Hanly at Rm. 6049, Bond Wing, St. Michael's Hospital, 30 Bond St., Toronto, ON M5B 1W8, Canada, or at .

References

References

  1. 1

    Fletcher EC. Obstructive sleep apnea and the kidney. J Am Soc Nephrol 1993;4:1111-1121
    Web of Science | Medline

  2. 2

    Kraus MA. Sleep apnea in renal failure. Adv Perit Dial 1997;13:88-92
    Medline

  3. 3

    Onal E. Sleep-disordered breathing in patients with end-stage renal disease. Kidney 1993;2:309-311

  4. 4

    Kimmel PL. Sleep disorders in chronic renal disease. J Nephrol 1989;1:59-65

  5. 5

    Mendelson WB, Wadhwa NK, Greenberg HE, Gujavarty K, Bergofsky E. Effects of hemodialysis on sleep apnea syndrome in end-stage renal disease. Clin Nephrol 1990;33:247-251
    Web of Science | Medline

  6. 6

    Langevin B, Fouque D, Leger P, Robert D. Sleep apnea syndrome and end-stage renal disease: cure after renal transplantation. Chest 1993;103:1330-1335
    CrossRef | Web of Science | Medline

  7. 7

    Stepanski E, Faber M, Zorick F, Basner R, Roth T. Sleep disorders in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 1995;6:192-197
    Web of Science | Medline

  8. 8

    Auckley D, Schmidt-Nowara W, Brown LK. Reversal of sleep apnea hypopnea syndrome in end-stage renal disease after kidney transplantation. Am J Kidney Dis 1999;34:739-744
    CrossRef | Web of Science | Medline

  9. 9

    Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998;9:859-868
    Web of Science | Medline

  10. 10

    O'Sullivan DA, McCarthy JT, Kumar R, Williams AW. Improved biochemical variables, nutrient intake, and hormonal factors in slow nocturnal hemodialysis: a pilot study. Mayo Clin Proc 1998;73:1035-1045
    CrossRef | Web of Science | Medline

  11. 11

    Mucsi I, Hercz G, Uldall R, Ouwendyk M, Francoeur R, Pierratos A. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998;53:1399-1404
    CrossRef | Web of Science | Medline

  12. 12

    Raj DS, Ouwendyk M, Francoeur R, Pierratos A. Beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000;15:58-64
    CrossRef | Web of Science | Medline

  13. 13

    Pierratos A. Nocturnal hemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999;14:2835-2840
    CrossRef | Web of Science | Medline

  14. 14

    Brissenden JE, Pierratos A, Ouwendyk M, Roscoe JM. Improvements in quality of life with nocturnal hemodialysis. J Am Soc Nephrol 1998;9:Suppl:168A-168A abstract.

  15. 15

    Rechtschaffen A, Kales A, eds. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, 1968:1-60.

  16. 16

    Periodic limb movement disorder. In: Diagnostic Classification Steering Committee. The international classification of sleep disorders: diagnostic and coding manual. Rochester, Minn.: American Sleep Disorders Association, 1990:65-8.

  17. 17

    Millman RP, Kimmel PL, Shore ET, Wasserstein AG. Sleep apnea in hemodialysis patients: the lack of testosterone effect on its pathogenesis. Nephron 1985;40:407-410
    CrossRef | Medline

  18. 18

    Soreide E, Skeie B, Kirvela O, et al. Branched-chain amino acid in chronic renal failure patients: respiratory and sleep effects. Kidney Int 1991;40:539-543
    CrossRef | Web of Science | Medline

  19. 19

    Hamilton RW, Epstein PE, Henderson LW, Edelman NH, Fishman AP. Control of breathing in uremia: ventilatory response to CO2 after hemodialysis. J Appl Physiol 1976;41:216-222
    Web of Science | Medline

  20. 20

    Wilcox I, McNamara SG, Dodd MJ, Sullivan CE. Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea. Eur Respir J 1998;11:7-13
    CrossRef | Web of Science | Medline

  21. 21

    Hudgel DW, Chapman KR, Faulks C, Hendricks C. Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxia during sleep. Am Rev Respir Dis 1987;135:899-906
    Web of Science | Medline

  22. 22

    Onal E, Burrows DL, Hart RH, Lopata M. Induction of periodic breathing during sleep causes upper airway obstruction in humans. J Appl Physiol 1986;61:1438-1443
    Web of Science | Medline

Citing Articles (142)

Citing Articles

  1. 1

    A. Covic, L. Voroneanu, F. Locatelli. (2012) Uraemic toxins versus volume and water as the major factor that matters with dialysis. Nephrology Dialysis Transplantation 27:1, 58-62
    CrossRef

  2. 2

    Katalin Fornadi, Anett Lindner, Maria E. Czira, Andras Szentkiralyi, Alpar S. Lazar, Rezso Zoller, Csilla Z. Turanyi, Orsolya Veber, Marta Novak, Istvan Mucsi, Miklos Z. Molnar. (2011) Lack of association between objectively assessed sleep disorders and inflammatory markers among kidney transplant recipients. International Urology and Nephrology
    CrossRef

  3. 3

    R. M. Elias, T. D. Bradley, T. Kasai, S. S. Motwani, C. T. Chan. (2011) Rostral overnight fluid shift in end-stage renal disease: relationship with obstructive sleep apnea. Nephrology Dialysis Transplantation
    CrossRef

  4. 4

    Michael V Rocco, Robert S Lockridge, Gerald J Beck, Paul W Eggers, Jennifer J Gassman, Tom Greene, Brett Larive, Christopher T Chan, Glenn M Chertow, Michael Copland, Christopher D Hoy, Robert M Lindsay, Nathan W Levin, Daniel B Ornt, Andreas Pierratos, Mary F Pipkin, Sanjay Rajagopalan, John B Stokes, Mark L Unruh, Robert A Star, Alan S Kliger, A Kliger, P Eggers, J Briggs, T Hostetter, A Narva, R Star, B Augustine, P Mohr, G Beck, Z Fu, J Gassman, T Greene, J Daugirdas, L Hunsicker, B Larive, M Li, J MacKrell, K Wiggins, S Sherer, B Weiss, S Rajagopalan, J Sanz, S Dellagrottaglie, M Kariisa, T Tran, J West, M Unruh, R Keene, J Schlarb, C Chan, M McGrath-Chong, R Frome, H Higgins, S Ke, O Mandaci, C Owens, C Snell, G Eknoyan, L Appel, A Cheung, A Derse, C Kramer, N Geller, R Grimm, L Henderson, S Prichard, E Roecker, M Rocco, B Miller, J Riley, R Schuessler, R Lockridge, M Pipkin, C Peterson, C Hoy, A Fensterer, D Steigerwald, J Stokes, D Somers, A Hilkin, K Lilli, W Wallace, B Franzwa, E Waterman, C Chan, M McGrath-Chong, M Copland, A Levin, L Sioson, E Cabezon, S Kwan, D Roger, R Lindsay, R Suri, J Champagne, R Bullas, A Garg, A Mazzorato, E Spanner, M Rocco, J Burkart, S Moossavi, V Mauck, T Kaufman, A Pierratos, W Chan, K Regozo, S Kwok. (2011) The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney International 80:10, 1080-1091
    CrossRef

  5. 5

    Nathan W. Levin, Jochen G. Raimann, Michael V. Rocco. (2011) Should the knowledge gained from the Frequent Hemodialysis Network (FHN) trials change dialysis practice?. Current Opinion in Nephrology and Hypertension 20:6, 577-582
    CrossRef

  6. 6

    John B. Stokes. (2011) Nocturnal Hemodialysis: Analysis Following the Frequent Hemodialysis Network Trial. Seminars in Dialysisno-no
    CrossRef

  7. 7

    Simon P. Curran, Christopher T. Chan. (2011) Intensive Hemodialysis: Normalizing the “Unphysiology” of Conventional Hemodialysis?. Seminars in Dialysisno-no
    CrossRef

  8. 8

    José Haba-Rubio, Sophie de Seigneux, Raphael Heinzer. (2011) Troubles du sommeil et maladie rénale chronique. Néphrologie & Thérapeutique
    CrossRef

  9. 9

    A. Fritz, L.C. Rump. (2011) Niereninsuffizienz und schlafbezogene Atemstörungen. Somnologie - Schlafforschung und Schlafmedizin 15:3, 160-164
    CrossRef

  10. 10

    Birgit Koch, Marije Russcher, J Nagtegaal. 2011. Melatonin and Sleep Disturbances in Patients with End-Stage Renal Disease. , 495-507.
    CrossRef

  11. 11

    T. Masuda, M. Murata, S. Honma, Y. Iwazu, N. Sasaki, M. Ogura, A. Onishi, Y. Ando, S. Muto, K. Shimada, K. Kario, E. Kusano, Y. Asano. (2011) Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrology Dialysis Transplantation 26:7, 2289-2295
    CrossRef

  12. 12

    Jing Feng, Dan Zhang, Baoyuan Chen. (2011) Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep and Breathing
    CrossRef

  13. 13

    Asiye Kanbay, Hakan Buyukoglan, Nezihe Ozdogan, Elif Kaya, Fatma Sema Oymak, Inci Gulmez, Ramazan Demir, Oguz Kokturk, Adrian Covic. (2011) Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. International Urology and Nephrology
    CrossRef

  14. 14

    Philip A McFarlane. (2011) Nocturnal hemodialysis: effects on solute clearance, quality of life, and patient survival. Current Opinion in Nephrology and Hypertension 20:2, 182-188
    CrossRef

  15. 15

    Mark L. Unruh, Mark H. Sanders. 2011. Sleep in Chronic Kidney Disease. , 1462-1472.
    CrossRef

  16. 16

    Jeong Jin Lee, Gaab Soo Kim, Jie Ae Kim, Sung-Joo Kim, Jin Gu Kang, Gunn Hee Kim, Hae Hyuk Jung. (2011) Improvement of sleep-related breathing disorder in patients with end-stage renal disease after kidney transplantation. Clinical Transplantation 25:1, 126-130
    CrossRef

  17. 17

    Steven R. Barczi, Mihai Teodorescu. 2011. Medical and Psychiatric Disorders and the Medications Used to Treat Them. , 1524-1535.
    CrossRef

  18. 18

    Robert M. LINDSAY, Rita S. SURI, Louise M. MOIST, Amit X. GARG, Meaghan CUERDEN, Sarah LANGFORD, Raymond HAKIM, Norma J. OFSTHUN, Stephen P. MCDONALD, Carmel HAWLEY, Ferqus J. CASKEY, Cecile COUCHOUD, Christian AWARAJI, Gihad E. NESRALLAH. (2011) International quotidian dialysis registry: Annual report 2010. Hemodialysis International 15:1, 15-22
    CrossRef

  19. 19

    Mitchell H. Rosner. (2010) Home hemodialysis: Present state of the evidence. Dialysis & Transplantation 39:8, 330-334
    CrossRef

  20. 20

    K Gaddam, E Pimenta, S J Thomas, S S Cofield, S Oparil, S M Harding, D A Calhoun. (2010) Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. Journal of Human Hypertension 24:8, 532-537
    CrossRef

  21. 21

    C. J. O. Rodrigues, O. Marson, S. M. G. P. Togeiro, S. Tufik, A. B. Ribeiro, A. Tavares. (2010) Sleep-disordered breathing changes after kidney transplantation:a polysomnographic study. Nephrology Dialysis Transplantation 25:6, 2011-2015
    CrossRef

  22. 22

    NIGEL D TOUSSAINT. (2010) Review: Differences in prescription between conventional and alternative haemodialysis. Nephrology 15:4, 399-405
    CrossRef

  23. 23

    JOHN J SIM, SCOTT A RASGON, STEPHEN F DEROSE. (2010) Review article: Managing sleep apnoea in kidney diseases. Nephrology 15:2, 146-152
    CrossRef

  24. 24

    Kenneth R. Casey. (2010) Sleep disorders in chronic kidney disease. Sleep Medicine 11:3, 231-232
    CrossRef

  25. 25

    M. Haag-Weber. (2010) Intensivierte Hämodialyse. Der Nephrologe 5:2, 155-161
    CrossRef

  26. 26

    Birgit C.P. Koch, J. Elsbeth Nagtegaal, E. Christiaan Hagen, Pieter M. ter Wee, Gerard A. Kerkhof. (2010) Different melatonin rhythms and sleep–wake rhythms in patients on peritoneal dialysis, daytime hemodialysis and nocturnal hemodialysis. Sleep Medicine 11:3, 242-246
    CrossRef

  27. 27

    Mehmood Butt, Girish Dwivedi, Omer Khair, Gregory Y.H. Lip. (2010) Obstructive sleep apnea and cardiovascular disease. International Journal of Cardiology 139:1, 7-16
    CrossRef

  28. 28

    Emma Ball, Tonya Kara, David McNamara, Elizabeth A. Edwards. (2010) Resolution of sleep-disordered breathing in a dialysis-dependent child post-renal transplantation. Pediatric Nephrology 25:1, 173-177
    CrossRef

  29. 29

    I. Quack, A. Fritz, L.C. Rump. (2010) Schlafapnoesyndrom bei chronischer Niereninsuffizienz. Der Nephrologe 5:1, 43-48
    CrossRef

  30. 30

    G. Fleischmann, G. Fillafer, H. Matterer, F. Skrabal, P. Kotanko. (2010) Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrology Dialysis Transplantation 25:1, 181-186
    CrossRef

  31. 31

    G. Bayliss, J. Danziger. (2009) Nocturnal versus conventional haemodialysis: some current issues. Nephrology Dialysis Transplantation 24:12, 3612-3617
    CrossRef

  32. 32

    Philip A. McFarlane. (2009) More of the Same: Improving Outcomes Through Intensive Hemodialysis. Seminars in Dialysis 22:6, 598-602
    CrossRef

  33. 33

    Fredric O Finkelstein, Diane Wuerth, Susan H Finkelstein. (2009) Health related quality of life and the CKD patient: challenges for the nephrology community. Kidney International 76:9, 946-952
    CrossRef

  34. 34

    Kirsten L Johansen, Rebecca Zhang, Yijian Huang, Shu-Cheng Chen, Christopher R Blagg, Alexander S Goldfarb-Rumyantzev, Chistopher D Hoy, Robert S Lockridge, Brent W Miller, Paul W Eggers, Nancy G Kutner. (2009) Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney International 76:9, 984-990
    CrossRef

  35. 35

    Safwan Badr. (2009) Central sleep apnea in patients with congestive heart failure. Heart Failure Reviews 14:3, 135-141
    CrossRef

  36. 36

    Birgit C. P. Koch, J. Elsbeth Nagtegaal, Gerard A. Kerkhof, Piet M. ter Wee. (2009) Circadian sleep–wake rhythm disturbances in end-stage renal disease. Nature Reviews Nephrology 5:7, 407-416
    CrossRef

  37. 37

    F. Mallamaci, D. Leonardis, R. Tripepi, G. Parlongo, C. Catalano, G. Tripepi, V. Castronovo, L. Ferini-Strambi, C. Zoccali. (2009) Sleep Disordered Breathing in Renal Transplant Patients. American Journal of Transplantation 9:6, 1373-1381
    CrossRef

  38. 38

    Miklos Zsolt Molnar, Marta Novak, Istvan Mucsi. (2009) Sleep disorders and quality of life in renal transplant recipients. International Urology and Nephrology 41:2, 373-382
    CrossRef

  39. 39

    Stephanie S. DeLoach, Jeffrey S. Berns. (2009) Impact of Obstructive Sleep Apnea in Hemodialysis Patients. Seminars in Dialysis 22:3, 308-310
    CrossRef

  40. 40

    Patrick Hanly. (2009) Sleep Disorders and Home Dialysis. Advances in Chronic Kidney Disease 16:3, 179-188
    CrossRef

  41. 41

    Babak Barmar, Qianyu Dang, Daniel Isquith, Daniel Buysse, Mark Unruh. (2009) Comparison of Sleep/Wake Behavior in CKD Stages 4 to 5 and Hemodialysis Populations Using Wrist Actigraphy. American Journal of Kidney Diseases 53:4, 665-672
    CrossRef

  42. 42

    Birgit C.P. Koch, E. Christiaan Hagen, J. Elsbeth Nagtegaal, Jan B.S. Boringa, Gerard A. Kerkhof, Piet M. Ter Wee. (2009) Effects of Nocturnal Hemodialysis on Melatonin Rhythm and Sleep-Wake Behavior: An Uncontrolled Trial. American Journal of Kidney Diseases 53:4, 658-664
    CrossRef

  43. 43

    Tomokazu Matsuura, Munekazu Ryuzaki, Mika Asanagi, Katsufumi Sakata, Kayo Oku, Emi Kobayashi, Hirotoshi Aoki, Michiko Handa. (2009) Erythrocytosis associated with increased serum erythropoietin in a patient on hemodialysis. Nihon Toseki Igakkai Zasshi 42:8, 581-586
    CrossRef

  44. 44

    Jaime M. Beecroft, James Duffin, Andreas Pierratos, Christopher T. Chan, Philip McFarlane, Patrick J. Hanly. (2009) Decreased chemosensitivity and improvement of sleep apnea by nocturnal hemodialysis. Sleep Medicine 10:1, 47-54
    CrossRef

  45. 45

    Sudhansu Chokroverty. 2009. Sleep Disturbances in General Medical Disorders. , 550-580.
    CrossRef

  46. 46

    Kenneth R. Casey, Lee K. Brown. (2009) Sleep-disordered breathing and renal failure: A search for fundamental mechanisms. Sleep Medicine 10:1, 15-18
    CrossRef

  47. 47

    Nancy G. Kutner. (2008) Promoting functioning and well-being in older CKD patients: review of recent evidence. International Urology and Nephrology 40:4, 1151-1158
    CrossRef

  48. 48

    Patrick Hanly. (2008) Sleep disorders and end-stage renal disease. Current Opinion in Pulmonary Medicine 14:6, 543-550
    CrossRef

  49. 49

    Dominik Müller, Miriam Zimmering, Christopher T. Chan, Philip A. McFarlane, Andreas Pierratos, Uwe Querfeld. (2008) Intensified hemodialysis regimens: neglected treatment options for children and adolescents. Pediatric Nephrology 23:10, 1729-1736
    CrossRef

  50. 50

    Chung-Yao Hsu, Chien-Te Lee, Yue-Joe Lee, Tiao-Lai Huang, Ching-Yi Yu, Lung-Chih Lee, King-Kwan Lam, Yu-Shu Chien, Feng-Rong Chuang, Kao-Tai Hsu. (2008) Better Sleep Quality and Less Daytime Symptoms in Patients on Evening Hemodialysis: A Questionnaire-based Study. Artificial Organs 32:9, 711-716
    CrossRef

  51. 51

    U. Kuhlmann, F. G. Bormann, H. F. Becker. (2008) Obstructive sleep apnoea: clinical signs, diagnosis and treatment. Nephrology Dialysis Transplantation 24:1, 8-14
    CrossRef

  52. 52

    Muna T. Canales, Brent C. Taylor, Areef Ishani, Reena Mehra, Michael Steffes, Katie L. Stone, Susan Redline, Kristine E. Ensrud. (2008) Reduced renal function and sleep-disordered breathing in community-dwelling elderly men. Sleep Medicine 9:6, 637-645
    CrossRef

  53. 53

    Virend K. Somers, David P. White, Raouf Amin, William T. Abraham, Fernando Costa, Antonio Culebras, Stephen Daniels, John S. Floras, Carl E. Hunt, Lyle J. Olson, Thomas G. Pickering, Richard Russell, Mary Woo, Terry Young. (2008) Sleep Apnea and Cardiovascular Disease. Journal of the American College of Cardiology 52:8, 686-717
    CrossRef

  54. 54

    M. T. Canales, L.-Y. Lui, B. C. Taylor, A. Ishani, R. Mehra, K. L. Stone, S. Redline, K. E. Ensrud, . (2008) Renal function and sleep-disordered breathing in older men. Nephrology Dialysis Transplantation 23:12, 3908-3914
    CrossRef

  55. 55

    Bernabé Jurado Gámez, Alejandro Martín-Malo, Mari Carmen Fernández Marín, Alberto Rodríguez-Benot, Natalia Pascual, Luis Muñoz Cabrera, Pedro Aljama. (2008) Trastornos del sueño en pacientes en lista de espera de trasplante renal. Archivos de Bronconeumología 44:7, 371-375
    CrossRef

  56. 56

    G. K. Sakkas, V. Liakopoulos, C. Karatzaferi, I. Stefanidis. (2008) Sleep quality and dialysis efficacy affect functional capacity in patients receiving haemodialysis therapy. Nephrology Dialysis Transplantation 23:8, 2703-2704
    CrossRef

  57. 57

    Andreas Pierratos. (2008) Does frequent nocturnal hemodialysis result in better outcomes than conventional thrice-weekly hemodialysis?. Nature Clinical Practice Nephrology 4:3, 132-133
    CrossRef

  58. 58

    Dan Negoianu, Joel D. Glickman, Jeffrey S. Berns. (2008) Summary and Comment: How Much Is Enough? The Impact of Frequent Hemodialysis. Seminars in Dialysis 21:2, 192-195
    CrossRef

  59. 59

    Robert S. Lockridge, John Moran. (2008) Hemodialysis at HomeSeries Editors: Bertrand L. Jaber and John Moran: Short Daily Hemodialysis and Nocturnal Hemodialysis at Home: Practical Considerations. Seminars in Dialysis 21:1, 49-53
    CrossRef

  60. 60

    András Tislér, Alexander G. Logan, Katalin Akócsi, László Tornóci, István Kiss. (2008) Circadian Variation of Death in Hemodialysis Patients. American Journal of Kidney Diseases 51:1, 53-61
    CrossRef

  61. 61

    Mark BENAROIA, Andreas PIERRATOS, Gihad E. NESRALLAH. (2008) A primer for the prescription of short-daily and nocturnal hemodialysis. Hemodialysis International 12:1, 23-29
    CrossRef

  62. 62

    Vassilios Liakopoulos, Georgios K. Sakkas, Christoforos D. Giannaki, Myrto Giannopoulou, Theodoros Eleftheriadis, Ioannis Stefanidis. (2008) Factors Affecting Quality of Sleep in Dialysis Patients: Preliminary Polysomnographic Evidence. Renal Failure 30:4, 475-476
    CrossRef

  63. 63

    Suraj Kapa, Elizabeth H. Nora, Eddie L. Greene, Virend K. Somers. 2008. Treatment of Sleep Disorders in Patients with Renal Dysfunction. , 791-794.
    CrossRef

  64. 64

    Adam M. Mirot, Edward G. Tessier, Michael J. Germain, Lewis M. Cohen. 2008. Neuropsychiatric Complications and Psychopharmacology of End-Stage Renal Disease. , 795-817.
    CrossRef

  65. 65

    Paul Gusbeth-Tatomir, Daniela Boisteanu, Anca Seica, Catalina Buga, Adrian Covic. (2007) Sleep disorders: a systematic review of an emerging major clinical issue in renal patients. International Urology and Nephrology 39:4, 1217-1226
    CrossRef

  66. 66

    Robert P. Pauly, Christopher T. Chan. (2007) CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Reversing the Risk Factor Paradox: Is Daily Nocturnal Hemodialysis the Solution?. Seminars in Dialysis 20:6, 539-543
    CrossRef

  67. 67

    Mark S. MACGREGOR. (2007) Alternatives to standard hemodialysis. Hemodialysis International 11:s2, S10-S16
    CrossRef

  68. 68

    Mark L. UNRUH. (2007) Sleep apnea and dialysis therapies: Things that go bump in the night?. Hemodialysis International 11:4, 369-378
    CrossRef

  69. 69

    Pushkar ARGEKAR, Valerie GRIFFIN, David LITAKER, Mahboob RAHMAN. (2007) Sleep apnea in hemodialysis patients: Risk factors and effect on survival. Hemodialysis International 11:4, 435-441
    CrossRef

  70. 70

    Meyer, Timothy W., Hostetter, Thomas H., . (2007) Uremia. New England Journal of Medicine 357:13, 1316-1325
    Full Text

  71. 71

    E. C. Mucenica, D. Boisteanu, J. A. Wirth, A. Cernomaz, A. Covic. (2007) Sleep-disordered breathing in patients with end-stage renal disease and long-term dialysis. Somnologie - Schlafforschung und Schlafmedizin 11:3, 211-215
    CrossRef

  72. 72

    Mónica Llombart, Eusebi Chiner, Elia Gómez-Merino, Ada Luz Andreu, Esther Pastor, Ana Camarasa. (2007) Síndrome de apnea central de origen multifactorial tratado mediante soporte ventilatorio domiciliario. Archivos de Bronconeumología 43:8, 467-471
    CrossRef

  73. 73

    Priya Anantharaman, Alvin H. Moss. (2007) Should the Medicare ESRD Program Pay for Daily Dialysis? An Ethical Analysis. Advances in Chronic Kidney Disease 14:3, 290-296
    CrossRef

  74. 74

    Michael V. Rocco. (2007) More Frequent Hemodialysis: Back to the Future?. Advances in Chronic Kidney Disease 14:3, e1-e9
    CrossRef

  75. 75

    Fredric O. Finkelstein, Susan H. Finkelstein, Diane Wuerth, Shirin Shirani, Laura Troidle. (2007) Hemodialysis at Home Series Editors: Bertrand L. Jaber and John Moran: Effects of Home Hemodialysis on Health-Related Quality of Life Measures. Seminars in Dialysis 20:3, 265-268
    CrossRef

  76. 76

    Eberhard RITZ, Ralf DIKOW, Marie-Luise GROSS. (2007) Dialysis, cardiovascular disease, and the future. Hemodialysis International 11:s1, S2-S11
    CrossRef

  77. 77

    Patrick Hanly. (2007) Sleep Disorders and End-Stage Renal Disease. Sleep Medicine Clinics 2:1, 59-66
    CrossRef

  78. 78

    Jeffrey Perl, Christopher T Chan. (2007) Sleep apnea in peritoneal dialysis: nocturnal versus continuous ambulatory treatment. Nature Clinical Practice Nephrology 3:2, 72-73
    CrossRef

  79. 79

    J Perl, M L Unruh, C T Chan. (2006) Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis?’. Kidney International 70:10, 1687-1693
    CrossRef

  80. 80

    R DESANTO, M BARTIROMO, M CESARE, N DESANTO, M CIRILLO. (2006) Sleeping Disorders in Patients With End-Stage Renal Disease and Chronic Kidney Disease. Journal of Renal Nutrition 16:3, 224-228
    CrossRef

  81. 81

    Pia Yngman-Uhlin, Ulla Edell-Gustafsson. (2006) Self-reported subjective sleep quality and fatigue in patients with peritoneal dialysis treatment at home. International Journal of Nursing Practice 12:3, 143-152
    CrossRef

  82. 82

    Marta Novak, David Mendelssohn, Colin M. Shapiro, Istvan Mucsi. (2006) Reviews: Diagnosis and Management of Sleep Apnea Syndrome and Restless Legs Syndrome in Dialysis Patients. Seminars in Dialysis 19:3, 210-216
    CrossRef

  83. 83

    Ambreen Gul, Naim Aoun, Edwin M. Trayner. (2006) UNRESOLVED ISSUES IN DIALYSIS: Why Do Patients Sleep on Dialysis?. Seminars in Dialysis 19:2, 152-157
    CrossRef

  84. 84

    V M Campese, N Mitra, D Sandee. (2006) Hypertension in renal parenchymal disease: Why is it so resistant to treatment?. Kidney International 69:6, 967-973
    CrossRef

  85. 85

    Nikolaos Markou, Maria Kanakaki, Pavlos Myrianthefs, Dimitrios Hadjiyanakos, Dimosthenis Vlassopoulos, Anastasios Damianos, Konstantinos Siamopoulos, Miltiadis Vasiliou, Stavros Konstantopoulos. (2006) Sleep-Disordered Breathing in Nondialyzed Patients with Chronic Renal Failure. Lung 184:1, 43-49
    CrossRef

  86. 86

    Akiko Noda, Shigeru Nakai, Taro Soga, Tatsuki Sugiura, Norihisa Iwayama, Kenji Maeda, Misaho Atarashi, Fumihiko Yasuma, Norio Ozaki, Mitsuhiro Yokota, Yasuo Koike. (2006) Factors Contributing to Sleep Disturbance and Hypnotic Drug Use in Hemodialysis Patients. Internal Medicine 45:22, 1273-1278
    CrossRef

  87. 87

    Marta Novak, Colin M. Shapiro, David Mendelssohn, Istvan Mucsi. (2006) Reviews: Diagnosis and Management of Insomnia in Dialysis Patients. Seminars in Dialysis 19:1, 25-31
    CrossRef

  88. 88

    JOHN WM AGAR. (2005) Nocturnal haemodialysis in Australia and New Zealand (Review Article). Nephrology 10:3, 222-230
    CrossRef

  89. 89

    Jennifer Lipson, Susan Lavoie, Deborah Zimmerman. (2005) Gabapentin-Induced Myopathy in 2 Patients on Short Daily Hemodialysis. American Journal of Kidney Diseases 45:6, e100-e104
    CrossRef

  90. 90

    K. P. Parker. (2005) Polysomnographic measures of nocturnal sleep in patients on chronic, intermittent daytime haemodialysis vs those with chronic kidney disease. Nephrology Dialysis Transplantation 20:7, 1422-1428
    CrossRef

  91. 91

    Michael Walsh, Bruce Culleton, Marcello Tonelli, Braden Manns. (2005) A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney International 67:4, 1500-1508
    CrossRef

  92. 92

    (2005) K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients. American Journal of Kidney Diseases 45, 16-153
    CrossRef

  93. 93

    Manjula Kurella, Rita S. Suri, Glenn M. Chertow. (2005) PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Frequent Hemodialysis and Psychosocial Function. Seminars in Dialysis 18:2, 132-136
    CrossRef

  94. 94

    Archana K. Shayamsunder, Samir S. Patel, Vivek Jain, Rolf A. Peterson, Paul L. Kimmel. (2005) PSYCHOSOCIAL FACTORS IN PATIENTS WITH CHRONIC KIDNEY DISEASE: Sleepiness, Sleeplessness, and Pain in End-Stage Renal Disease: Distressing Symptoms for Patients. Seminars in Dialysis 18:2, 109-118
    CrossRef

  95. 95

    Manjula Kurella, Glenn M. Chertow. (2005) Dialysis session length (“t”) as a determinant of the adequacy of dialysis. Seminars in Nephrology 25:2, 90-95
    CrossRef

  96. 96

    Andreas Pierratos, Phil McFarlane, Christopher T Chan. (2005) Quotidian dialysis – update 2005. Current Opinion in Nephrology and Hypertension 14:2, 119-124
    CrossRef

  97. 97

    Sergio FF Santos, Aldo J Peixoto. (2005) Hypertension in dialysis. Current Opinion in Nephrology and Hypertension 14:2, 111-118
    CrossRef

  98. 98

    F. Locatelli. (2005) Dialysis dose and frequency. Nephrology Dialysis Transplantation 20:2, 285-296
    CrossRef

  99. 99

    Ira D. Davis, Joshua Baron, Mary Ann O’Riordan, Carol L. Rosen. (2005) Sleep disturbances in pediatric dialysis patients. Pediatric Nephrology 20:1, 69-75
    CrossRef

  100. 100

    (2005) Tratamiento médico del SAHS. Archivos de Bronconeumología 41, 45-50
    CrossRef

  101. 101

    Melvin E. Laski. (2004) Opinion: What Unique Acid-Base Considerations Exist in Dialysis Patients?. Seminars in Dialysis 17:5, 361-364
    CrossRef

  102. 102

    Ehab Saad, Bernard Charra, Dominic S. C. Raj. (2004) HYPERTENSION IN HEMODIALYSIS PATIENTS: Hypertension Control with Daily Dialysis. Seminars in Dialysis 17:4, 295-298
    CrossRef

  103. 103

    I. Mucsi. (2004) Sleep disorders and illness intrusiveness in patients on chronic dialysis. Nephrology Dialysis Transplantation 19:7, 1815-1822
    CrossRef

  104. 104

    P. J. Blankestijn. (2004) Sympathetic hyperactivity in chronic kidney disease. Nephrology Dialysis Transplantation 19:6, 1354-1357
    CrossRef

  105. 105

    Jutta Neumann, Gerry Ligtenberg, Inge I. Klein, Hein A. Koomans, Peter J. Blankestijn. (2004) Sympathetic hyperactivity in chronic kidney disease: Pathogenesis, clinical relevance, and treatment. Kidney International 65:5, 1568-1576
    CrossRef

  106. 106

    Andreas Pierratos. (2004) Daily nocturnal home hemodialysis. Kidney International 65:5, 1975-1986
    CrossRef

  107. 107

    Brendan B. McCormick, Christopher T. Chan. (2004) Improved blood pressure control with nocturnal hemodialysis: Review of clinical observations and physiologic mechanisms. Current Hypertension Reports 6:2, 140-144
    CrossRef

  108. 108

    Philip A. McFarlane. (2004) DAILY HEMODIALYSIS-SELECTED TOPICS: Reducing Hemodialysis Costs: Conventional and Quotidian Home Hemodialysis in Canada. Seminars in Dialysis 17:2, 118-124
    CrossRef

  109. 109

    Nancy G. Kutner. (2004) DAILY HEMODIALYSIS-SELECTED TOPICS: Quality of Life and Daily Hemodialysis. Seminars in Dialysis 17:2, 92-98
    CrossRef

  110. 110

    Christopher T. Chan. (2004) DAILY HEMODIALYSIS-SELECTED TOPICS: Cardiovascular Effects of Frequent Intensive Hemodialysis. Seminars in Dialysis 17:2, 99-103
    CrossRef

  111. 111

    Patrick Hanly. (2004) DAILY HEMODIALYSIS-SELECTED TOPICS: Sleep Apnea and Daytime Sleepiness in End-Stage Renal Disease. Seminars in Dialysis 17:2, 109-114
    CrossRef

  112. 112

    Gihad E. Nesrallah, Louise M. Moist, Christian Awaraji, Robert M. Lindsay. (2004) DAILY HEMODIALYSIS-SELECTED TOPICS: An International Registry to Compare Quotidian Dialysis Regimens with Conventional Thrice-Weekly Hemodialysis: Why, How, and Potential Pitfalls. Seminars in Dialysis 17:2, 131-135
    CrossRef

  113. 113

    Andreas Pierratos. (2004) DAILY HEMODIALYSIS-SELECTED TOPICS: Quotidian Hemodialysis: Is it the Solution to the Problem?. Seminars in Dialysis 17:2, 77-78
    CrossRef

  114. 114

    B. B. McCormick. (2004) Review of clinical outcomes in nocturnal haemodialysis patients after renal transplantation. Nephrology Dialysis Transplantation 19:3, 714-719
    CrossRef

  115. 115

    Andreas Pierratos. (2004) New Approaches to Hemodialysis. Annual Review of Medicine 55:1, 179-189
    CrossRef

  116. 116

    Christopher T. Chan, Pat Hanly, Jonathan Gabor, Peter Picton, Andreas Pierratos, John S. Floras. (2004) Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney International 65:2, 661-665
    CrossRef

  117. 117

    Hideki Kawanishi. (2004) Clinical Results of Daily Hemofiltration. Blood Purification 22:2, 8-13
    CrossRef

  118. 118

    Andreas Pierratos. (2004) Daily (quotidian) nocturnal home hemodialysis: Nine years later. Hemodialysis International 8:1, 45-50
    CrossRef

  119. 119

    V. E. Andreucci. (2004) Rights of chronic renal failure patients undergoing chronic dialysis therapy. Nephrology Dialysis Transplantation 19:1, 30-38
    CrossRef

  120. 120

    E. A. Iliescu. (2004) Quality of sleep in patients with chronic kidney disease. Nephrology Dialysis Transplantation 19:1, 95-99
    CrossRef

  121. 121

    John W.M. Agar, Christine A. Somerville, Karen M. Dwyer, Rosemary E. Simmonds, Janeane M. Boddington, Claire M. Waldron. (2003) Nocturnal Hemodialysis in Australia. Hemodialysis International 7:4, 278-289
    CrossRef

  122. 122

    Rajiv Agarwal. (2003) Systolic Hypertension in Hemodialysis Patients. Seminars in Dialysis 16:3, 208-213
    CrossRef

  123. 123

    Shiow-Luan Tsay, Jiin-Ru Rong, Pay-Fan Lin. (2003) THIS ARTICLE HAS BEEN RETRACTED Acupoints massage in improving the quality of sleep and quality of life in patients with end-stage renal disease. Journal of Advanced Nursing 42:2, 134-142
    CrossRef

  124. 124

    Kathy P. Parker. (2003) Sleep disturbances in dialysis patients. Sleep Medicine Reviews 7:2, 131-143
    CrossRef

  125. 125

    Harold J. Manley, George R. Bailie, Marcy L. Mcclaran, Walter L. Bender. (2003) Gentamicin pharmacokinetics during slow daily home hemodialysis. Kidney International 63:3, 1072-1078
    CrossRef

  126. 126

    Kathy P. Parker. (2003) Dialysis Clinic: Insomnia on Dialysis Nights. Seminars in Dialysis 16:1, 77-78
    CrossRef

  127. 127

    Zbylut J. Twardowski. (2003) We Should Strive for Optimal Hemodialysis: A Criticism of the Hemodialysis Adequacy Concept. Hemodialysis International 7:1, 5-16
    CrossRef

  128. 128

    Himmelfarb, Jonathan, . (2002) Success and Challenge in Dialysis Therapy. New England Journal of Medicine 347:25, 2068-2070
    Full Text

  129. 129

    Gaëlle Gillerot, Michel Jadoul. (2002) Obstructive sleep apnoea. The Lancet 360:9350, 2079
    CrossRef

  130. 130

    Bradley G. Phillips, Virend K. Somers. (2002) Sleep disordered breathing and risk factors for cardiovascular disease. Current Opinion in Pulmonary Medicine 8:6, 516-520
    CrossRef

  131. 131

    Aldo J. Peixoto, William B. White. (2002) Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Current Opinion in Nephrology and Hypertension 11:5, 507-516
    CrossRef

  132. 132

    Christopher T. Chan, John S. Floras, Judith A. Miller, Robert M.A. Richardson, Andreas Pierratos. (2002) Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney International 61:6, 2235-2239
    CrossRef

  133. 133

    Meryem Tuncel, Robert Augustyniak, Weiguo Zhang, Robert D. Toto, Ronald G. Victor. (2002) Sympathetic nervous system function in renal hypertension. Current Hypertension Reports 4:3, 229-236
    CrossRef

  134. 134

    Andreas Pierratos. (2002) Daily hemodialysis: an update. Current Opinion in Nephrology and Hypertension 11:2, 165-171
    CrossRef

  135. 135

    Romana Klefter, Bent Nielsen. (2002) Savings in Dialysis Treatment?. Artificial Organs 26:1, 49-54
    CrossRef

  136. 136

    Robert A. Augustyniak, Meryem Tuncel, Weiguo Zhang, Robert D. Toto, Ronald G. Victor. (2002) Sympathetic overactivity as a cause of hypertension in chronic renal failure. Journal of Hypertension 20:1, 3-9
    CrossRef

  137. 137

    Debra Passehl, Elizabeth Langer, Jean Verbrick, Paul J. Drinka. (2002) Overnight Pulse Oximetry in Nursing Home Residents with Behavior Problems: Case Reports. Journal of the American Medical Directors Association 3:1, 26-28
    CrossRef

  138. 138

    Carl M. Kjellstrand. (2001) Rationale for Daily Hemodialysis. ASAIO Journal 47:5, 438-442
    CrossRef

  139. 139

    Andreas Pierratos. (2001) The Case for Nocturnal Hemodialysis. ASAIO Journal 47:5, 446-448
    CrossRef

  140. 140

    Richard A. Sherman. (2001) Briefly noted. Seminars in Dialysis 14:5, 407-408
    CrossRef

  141. 141

    Andreas Pierratos. (2001) Effect of Therapy Time and Frequency on Effective Solute Removal. Seminars in Dialysis 14:4, 284-288
    CrossRef

  142. 142

    Friedman, Eli A., . (2001) Hemodialysis as an Artificial Lung in Sleep Apnea. New England Journal of Medicine 344:2, 134-135
    Full Text